AS26478 — NOVARTIS-PHARMA

AS26478 announces 6 IPv4 prefixes covering 1,808 addresses and 0 IPv6 prefixes.

About this network

The AS handle NOVARTIS-PHARMA is held by Novartis Pharmaceuticals.

What it's used for

• The address space carries corporate infrastructure for the pharmaceutical giant, evidenced by netnames such as NOVARTIS-DMZ-US, US-NOVARTIS-20220912, and MX-NOVARTIS-20210419.
• The AS announces 1808 IPv4 addresses across 6 prefixes while maintaining only 6 observed neighbours, a ratio indicative of an internal corporate estate rather than a transit or access network.

Notable

• Registrants for the majority of prefixes align with the announcer, listing Novartis AG contacts for NOVARTIS-DMZ-US, US-NOVARTIS-20220912, MX-NOVARTIS-20210419, and US-NOVARTIS-20190905.
• The inventory includes two prefixes with different registrants: 205.181.102.0/24 is registered to Level 3 Parent, LLC, and 200.57.1.48/28 is registered to Operbes, S.A. de C.V., suggesting leased or legacy space.
• The address inventory is finely subdivided into small blocks, consistent with site-by-site segmentation for a large multinational corporation.

This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy.

Announced prefixes

• 86.117.47.0/24
• 160.62.14.0/23
• 160.62.140.0/23
• 162.86.66.0/24
• 200.57.1.48/28
• 205.181.102.0/24

Upstream networks

• AS6461 Zayo Bandwidth
• AS54004 Cablevision Lightpath LLC
• AS3300 British Telecommunications Limited
• AS3356 Level 3 Parent, LLC
• AS400317 GoldConnect
• AS18734 Operbes, S.A. de C.V.

Adjacent networks

• AS6461 Zayo Bandwidth
• AS54004 Cablevision Lightpath LLC
• AS3300 British Telecommunications Limited
• AS3356 Level 3 Parent, LLC
• AS400317 GoldConnect
• AS18734 Operbes, S.A. de C.V.